HM
Therapeutic Areas
ALK Abello Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EURneffy® 1mg | Anaphylaxis (Pediatric) | Approved |
| EURneffy® | Anaphylaxis | Approved |
| Respiratory AIT Portfolio | Allergic Rhinitis/Asthma | Commercial |
| Peanut Allergy Program | Peanut Allergy | Development |
| Adjacent Therapy Programs | Type 2 Immune Disorders | Pre-clinical |